Page 104 - Characterization of genetic neurodevelopmental disorders at adult age, with a focus on 22q11.2 deletion syndrome - Emma Boersma

Chapter 2
Supplement 1)71st Annual Meeting of the American Academy of Neurology, AAN 2019. United
States.
35. Zitser J, Giladi N, Gurevich T. A Case with Beta-Propeller Protein Associated Neurodegeneration
with Smooth Response to Levodopa Treatment. Movement Disorders Clinical Practice.
2018;5(3):327-329. doi:http://dx.doi.org/10.1002/mdc3.12604
36. Endo H, Uenaka T, Satake W, et al. Japanese WDR45 de novo mutation diagnosed by exome
analysis: A case report. Neurol Clin Neurosci. Jul 2017;5(4):131-133. doi:10.1111/ncn3.12132
37. Dotti MT, Federico A, Garuti R, Calandra S. Cerebrotendinous xanthomatosis with predominant
parkinsonian syndrome: further confirmation of the clinical heterogeneity. Mov Disord. Sep
2000;15(5):1017-9. doi:10.1002/1531-8257(200009)15:5<1017::aid-mds1043>3.0.co;2-f
38. Fujiyama J, Kuriyama M, Yoshidome H, et al. Parkinsonism in cerebrotendinous xanthomatosis.
Jpn J Med. Mar-Apr 1991;30(2):189-92. doi:10.2169/internalmedicine1962.30.189
39. Grandas F, Martin-Moro M, Garcia-Munozguren S, Anaya F. Early-onset parkinsonism
in cerebrotendinous xanthomatosis. Mov Disord. Nov 2002;17(6):1396-7. doi:10.1002/
mds.10287
40. Kuwabara K, Hitoshi S, Nukina N, et al. PET analysis of a case of cerebrotendinous
xanthomatosis presenting hemiparkinsonism. J Neurol Sci. Jun 1996;138(1-2):145-9.
doi:10.1016/0022-510x(96)00011-1
41. Li J, Xu EH, Mao W, et al. Parkinsonism with Normal Dopaminergic Presynaptic Terminals in
Cerebrotendinous Xanthomatosis. Mov Disord Clin Pract. Jan 2020;7(1):115-116. doi:10.1002/
mdc3.12846
42. Mignarri A, Falcini M, Vella A, et al. Parkinsonism as neurological presentation of late-
onset cerebrotendinous xanthomatosis. Parkinsonism Relat Disord. Jan 2012;18(1):99-101.
doi:10.1016/j.parkreldis.2011.06.004
43. Pilo de la Fuente B, Ruiz I, Lopez de Munain A, Jimenez-Escrig A. Cerebrotendinous
xanthomatosis: neuropathological findings. J Neurol. Jun 2008;255(6):839-42. doi:10.1007/
s00415-008-0729-6
44. Schotsmans K, De Cauwer H, Baets J, et al. Cerebrotendinous xanthomatosis presenting with
asymmetric parkinsonism: a case with I-123-FP-CIT SPECT imaging. Acta Neurol Belg. Sep
2012;112(3):287-9. doi:10.1007/s13760-012-0064-7
45. Su CS, Chang WN, Huang SH, et al. Cerebrotendinous xanthomatosis patients with and
without parkinsonism: clinical characteristics and neuroimaging findings. Mov Disord. Mar 15
2010;25(4):452-8. doi:10.1002/mds.22979
46. Wakamatsu N, Hayashi M, Kawai H, et al. Mutations producing premature termination
of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause
cerebrotendinous xanthomatosis associated with parkinsonism. J Neurol Neurosurg Psychiatry.
Aug 1999;67(2):195-8. doi:10.1136/jnnp.67.2.195
47. Yunisova G, Tufekcioglu Z, Dogu O, et al. Patients with Lately Diagnosed Cerebrotendinous
Xanthomatosis. Neurodegener Dis. Apr 29 2020:1-7. doi:10.1159/000506770
48. Zadori D, Szpisjak L, Madar L, et al. Different phenotypes in identical twins with cerebrotendinous
xanthomatosis: case series. Neurol Sci. Mar 2017;38(3):481-483. doi:10.1007/s10072-016-
2776-6
49. Rubio-Agusti I, Kojovic M, Edwards MJ, et al. Atypical parkinsonism and cerebrotendinous
xanthomatosis: report of a family with corticobasal syndrome and a literature review. Mov
Disord. Dec 2012;27(14):1769-74. doi:10.1002/mds.25229
50. Manti F, Nardecchia F, Barresi S, et al. Neurotransmitter trafficking defect in a patient with
clathrin (CLTC) variation presenting with intellectual disability and early-onset parkinsonism.
Parkinsonism Relat Disord. Apr 2019;61:207-210. doi:10.1016/j.parkreldis.2018.10.012
51. Fernandez HH, Friedman JH, Famiglietti EV. Probable Cornelia de Lange syndrome with
progressive parkinsonism and dystonia. Mov Disord. Jul 2000;15(4):749-51. doi:10.1002/1531-
8257(200007)15:4<749::aid-mds1028>3.0.co;2-p
52. Rana S. Multidisciplinary care of a patient with cowden syndrome at a geriatric center. Journal
of the American Geriatrics Society. 2018;66(Supplement 2):S187. 2018 Annual Scientific
Meeting of the American Geriatrics Society, AGS 2018. United States. doi:http://dx.doi.
org/10.1111/jgs.15376
102